Expression data of different types of OSAHS patients

OSAHS is a complex,synthetical disease that can lead to multiple system and multiple organ damage as the disease progresses.Metabolic syndrome is the most common complication, but the symptoms at different stages of the disease are different.It is known that miRNAs can be stably in the serum and changes during the development of the disease.Therefore, we speculate that serum miRNAs could biomarkers for OSAHS diagnosis and progression judgment. We used microarrays to detail the miRNA expression of simple OSAHS patients, OSAHS patients with hypertension and healthy controls, and screened out the miRNAs that were differentially expressed between the two groups. Participants were divided into three groups: simple OSAHS patients and OSAHS patients with hypertension and healthy controls.Five serum from each group were selected for RNA extraction and hybridization on Affymetrix microarrays.